Similar articles

• Infectious mononucleosis hepatitis.

  White NJ, Juel-Jensen BE. White NJ, et al. Semin Liver Dis. 1984 Nov;4(4):301-6. doi: 10.1055/s-2008-1040659. Semin Liver Dis. 1984. PMID: 6098015 Review. No abstract available.
• [Infectious mononucleosis. Epidemiology, diagnosis, development].

  Buisson M, Chavanet P. Buisson M, et al. Rev Prat. 2000 Jun 1;50(11):1253-6. Rev Prat. 2000. PMID: 11008509 Review. French. No abstract available.
• [CLINICAL AND IMMUNOLOGICAL CRITERIA FOR THE ADVERSE COURSE OF INFECTIOUS MONONUCLEOSIS IN CHILDREN].

  Kolesnik Y, Zharkova T, Rzhevskaya O, Kvaratskheliya T, Sorokina O. Kolesnik Y, et al. Georgian Med News. 2018 May;(278):132-138. Georgian Med News. 2018. PMID: 29905559 Russian.
• [EBV serology and quality control in the year 2000].

  Lindecker V, Burg E, Maisonneuve P, Seigneurin JM. Lindecker V, et al. Ann Biol Clin (Paris). 2001 Oct;59 Spec No:34-6. Ann Biol Clin (Paris). 2001. PMID: 11675292 French. No abstract available.
• Infectious mononucleosis and fatal myocarditis.

  Frishman W, Kraus ME, Zabkar J, Brooks V, Alonso D, Dixon LM. Frishman W, et al. Chest. 1977 Oct;72(4):535-8. doi: 10.1378/chest.72.4.535. Chest. 1977. PMID: 198186